Boris Bernhardt wins CAN's 2022 New Investigator Award
Together with Dr. Birgit Frauscher, Bernhardt co-directs The Neuro鈥檚 new Centre of Excellence in EpilepsySince joining The Neuro in 2016, Boris Bernhardt, PhD, Assistant Professor of Neurology and Neurosurgery, has published pioneering research on the organization and development of the healthy brain. His achievements have been recognized this week by the Canadian Association for Neuroscience, who have awarded him the 2022 New Investigator Award.
Big data analysis suggests role of brain connectivity in epilepsy-related atrophy
Large multi-site study accurately predicts damage to grey matter by disease
An international study has found a link between the brain鈥檚 network connections and grey matter atrophy caused by certain types of epilepsy, a major step forward in our understanding of the disease.
Four early-career researchers receive leadership grants
Brain Canada program supports paradigm-shifting neuroscience that improves the lives of Canadians
Four researchers at The Neuro 鈥� Boris Bernhardt, Yasser Iturria-Medina, Jean-Francois Poulin, and Jo Anne Stratton 鈥� have received grants to support their work in the early-career stage, after being chosen from 150 talented applicants.
Epilepsy research and care at The Neuro
The institute that developed the 鈥淢ontreal Procedure鈥� continues to be on the cutting edgeThe Neuro is recognized worldwide as a leader in epilepsy research and treatment. From the beginning, Neuro founder, Dr. Wilder Penfield, made epilepsy a central focus. He and his colleagues developed a surgical treatment for epilepsy patients known as the 鈥淢ontreal Procedure,鈥� which today is in use throughout the world.
Epilepsy Day 2017
March 26 is Purple Day for Epilepsy, a day to support epilepsy awareness worldwide
